Genus (LON:GNS) Announces Earnings Results

Genus (LON:GNS) released its earnings results on Thursday. The company reported GBX 110.30 earnings per share for the quarter, Digital Look Earnings reports. Genus had a return on equity of 44.90% and a net margin of 43.35%.

Here are the key takeaways from Genus’ conference call:

• FY 2026 results were strong: adjusted profit before tax and adjusted EPS each rose 35%, while free cash flow increased to £62 million and leverage fell to 0.4x.
• Genus announced a £60 million share buyback for FY 2027 and recommended a 10% increase in the full-year dividend to 35.2 pence per share, reflecting confidence in cash generation and future growth.
• PIC delivered broad-based growth, including 52% royalty-revenue growth in China and market-share gains, while the new China joint venture is expected to support further expansion in the world’s largest porcine market.
• PRP regulatory progress continued with approvals or favorable determinations in Argentina, Canada, Uruguay, and Peru; commercialization is now beginning in selected Latin American markets, although approvals in Mexico and China remain pending.
• Management expects FY 2027 underlying adjusted profit before tax to be only moderately higher, with growth weighted toward the second half due to weak agricultural markets, North American disease pressures, lower Brazilian growth, depressed dairy conditions, and higher PRP and product-development costs.

Genus Stock Up 1.5%

GNS stock opened at GBX 2,192 on Friday. The firm has a market cap of £1.46 billion, a PE ratio of 30.87, a PEG ratio of 2.87 and a beta of 0.90. Genus has a 1 year low of GBX 1,943 and a 1 year high of GBX 3,220. The company has a fifty day simple moving average of GBX 2,220.31 and a 200 day simple moving average of GBX 2,374.09. The company has a current ratio of 2.22, a quick ratio of 1.08 and a debt-to-equity ratio of 14.02.

Insider Buying and Selling

In related news, insider Celia Baxter bought 2,336 shares of the business’s stock in a transaction on Friday, June 26th. The shares were bought at an average cost of GBX 2,140 per share, for a total transaction of £49,990.40. 0.71% of the stock is owned by insiders.

Genus News Roundup

Here are the key news stories impacting Genus this week:

• Positive Sentiment: Genus reported higher FY26 pretax profit, reduced leverage and launched a £60 million share buyback. The repurchase signals management confidence in the company’s long-term growth prospects and could support earnings per share. Genus Launches £60 Mln Share Buyback Programme
• Positive Sentiment: Berenberg reaffirmed its Buy rating and set a GBX 3,350 price target, implying substantial upside from recent trading levels. Genus announces £60m buyback as FY profits rise
• Neutral Sentiment: Genus posted quarterly EPS of GBX 110.30, with a 9.70% return on equity and 7.07% net margin. The results provide evidence of profitability, but the market reaction indicates investors were more concerned about forward guidance and revenue performance. Genus quarterly earnings
• Negative Sentiment: Management forecast moderate FY27 operating-profit growth, while FY26 revenue missed expectations. The combination has raised concerns about slower near-term momentum, outweighing the improved profit, lower debt and buyback news. Genus Shares Fall as Company Forecasts Moderate FY27 Growth

Analyst Ratings Changes

Separately, Berenberg Bank reissued a “buy” rating and issued a GBX 3,350 price target on shares of Genus in a research report on Thursday. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Genus presently has a consensus rating of “Buy” and a consensus price target of GBX 3,216.67.

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.